MVII-GCL is proposed, a novel multitask prediction framework built upon multiview information integration and graph contrastive learning that supports robustness against data sparsity and noise and its ability to discover potential associations.
Abstract
As a part of drug discovery, the exploration of circRNA-drug sensitivity associations (CRAs), drug-disease associations (RDAs) has been an important means of understanding disease mechanisms and proposing new treatment strategies. Due to the time-consuming and labor-intensive nature of biological experiments, computational methods have become effective solutions to this problem. However, existing computational methods for inferring CRAs, RDAs typically operate in isolation, failing to exploit the rich interplay across circRNAs, drugs, and diseases. In this paper, we propose MVII-GCL, a novel multitask prediction framework built upon multiview information integration and graph contrastive learning. MVII-GCL first constructs a multiview network encompassing attribute, topology, and association perspectives, explicitly tailored to capture the unique characteristics of each domain. To map multiview information into a unified latent space, our multiview attention encoder module employs domain-specific encoders to learn specialized representations, followed by a Top-k sparse attention mechanism. To further bolster robustness against data sparsity and noise, a symmetric graph contrastive learning objective is seamlessly integrated as a regularization term within the multitask learning paradigm. 5-fold cross-validation demonstrates our model's strong performance, achieving AUC, AUPR, and F1 scores of 0.9764, 0.9750, and 0.9234 in drug-disease association prediction, and 0.9301, 0.9339, and 0.8609 in circRNA-drug sensitivity prediction.Furthermore, case studies further support the model's ability to discover potential associations.
A multi-task prediction framework, capable of simultaneously predicting drug-disease, drug-protein, and disease-protein associations, is proposed, named MTP-DDA, demonstrating its effectiveness and robustness.
Ming-Li Cui, Cui-Na Jiao, Dao-Hui Ge et al.· Proceedings of the Thirty-Fi...· 0 citations
SGTL-DDA is proposed, a novel graph transformer framework designed to incorporate structural information and domain-specific knowledge from heterogeneous biological information networks (HBINs) that successfully identifies both known therapeutics and novel repositioning candidates, supported by molecular docking result...
Bowei Zhao, Hui Zhao, Yu-An Huang et al.· IEEE transactions on computa...· 0 citations
IDEAL (Interpretability-Driven Evolvable Attentive Learning for Microbe-Drug Association) is proposed, a multi-view framework that integrates drug network topological attributes, BERT-encoded drug semantics, drug fingerprints, microbe genome sequence attributes, BERT-encoded microbe semantics, and microbe metabolic pat...
MRGBMDAT, a multi-relational graph encoder network with bilinear fusion for miRNA-disease association type prediction significantly outperforms five state-of-the-art methods across multiple evaluation metrics, exhibiting strong discriminative power and generalization capability.
Y. Sun, Wen-Jing Su, Si-Qi Zhu et al.· Bioinform.· 0 citations
High-order dynamic disentangled framework for predicting ncRNA-drug resistance associations is proposed, suggesting that HDBI provides an effective and interpretable framework for prioritizing ncRNA-mediated drug resistance associations and guiding downstream mechanistic investigation.
Tiyao Liu, Shu-Dong Wang, Baoming Feng et al.· Journal of Chemical Informat...· 0 citations
This work proposes MFCAMNet, a Multi-Feature fusion and Cross-Self-Attention model for MiRNA–Disease association prediction, which employs element-level addition, element-level multiplication, and concatenation operations to generate miRNA-disease pair features with rich information.